Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 17, 2013

Aethersys, Amgen, Amneal, Aquinox, ArGEN-X, Asmacure, Boehringer Ingelheim, Hanmi, Ipsen, RedHill Biopharma, Sucampo, Takeda

Phase I
ArGEN-X hits dose escalation goals . . . read more

Phase II
Aquinox begins COPD trial . . . read more

Asmacure advances lead lung compound . . . read more

Phase III
Amgen MAb reduces LDL-C . . . read more

BI drug hits endpoint in VTE trial . . . read more

Ipsen’s Dysport posts positive results in spasticity trial . . . read more

RedHill begins dosing gastritis trial . . . read more

Sucampo, Takeda begin constipation trials . . . read more

Filings
Aethersys gets Orphan status in EU for stem cell GvHD therapy . . . read more

Launches
Amneal releases Nexium alternative . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters